Rikke Andersen

Medicine & Life Sciences

1. Melanoma 100%
2. Tumor-Infiltrating Lymphocytes 90%
3. T-Lymphocytes 73%
4. Cell- and Tissue-Based Therapy 55%
5. Ipilimumab 43%
6. 25-hydroxyvitamin D 39%
7. Neoplasms 35%
8. Vitamin D 34%
9. Immunotherapy 24%
10. Renal Cell Carcinoma 22%
11. Ovarian Neoplasms 21%
12. Denmark 21%
13. Bread 19%
14. Serum 18%
15. Adoptive Transfer 17%
16. T-Lymphocyte Subsets 17%
17. Interleukin-2 16%
18. Milk 14%
19. Therapeutics 11%
20. Child 11%
21. Neoplasm Antigens 10%
22. Frameshift Mutation 9%
23. Cholecalciferol 8%
24. Docetaxel 8%
25. Castration 8%
26. Sarcoidosis 8%
27. Antigens 8%
28. Alleles 7%
29. Vitamins 7%
30. Whole Exome Sequencing 7%
31. Antigen Presentation 7%
32. Point Mutation 7%
33. Positron-Emission Tomography 7%
34. Dendritic Cells 6%
35. Population 6%
36. Autoimmune Diseases 6%
37. Genes 6%
38. Vaccination 6%
39. Prostatic Neoplasms 6%
40. Organized Financing 6%
41. Single Nucleotide Polymorphism 5%
42. Randomized Controlled Trials 5%
43. Progression-Free Survival 5%
44. Vemurafenib 5%
45. Survival 5%